Jingwen Li

Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.

Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.

Journal: PloS one
Published: October 12, 2017

A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.

A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.

Journal: Oncotarget
Published: July 18, 2017

The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.

The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.

Journal: PloS one
Published: April 01, 2017

Identification of potential long non-coding RNA biomarkers associated with the progression of colon cancer.

Identification of potential long non-coding RNA biomarkers associated with the progression of colon cancer.

Journal: Oncotarget
Published: March 29, 2017

Expression of MYSM1 is associated with tumor progression in colorectal cancer.

Expression of MYSM1 is associated with tumor progression in colorectal cancer.

Journal: PloS one
Published: February 04, 2017

H3K4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer.

H3K4me3 and Wdr82 are associated with tumor progression and a favorable prognosis in human colorectal cancer.

Journal: Oncology letters
Published: December 27, 2016

USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.

USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.

Journal: Oncotarget
Published: October 12, 2016

Small interfering RNA targeting Rac1 sensitizes colon cancer to dihydroartemisinin-induced cell cycle arrest and inhibited cell migration by suppressing NFκB activity.

Small interfering RNA targeting Rac1 sensitizes colon cancer to dihydroartemisinin-induced cell cycle arrest and inhibited cell migration by suppressing NFκB activity.

Journal: Molecular and cellular biochemistry
Published: November 09, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026